Biotech · Private company · Saint Louis, MO, US
Senseion Therapeutics, Inc.
Track this companyFree. Adds Senseion Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetesFiscal year 2025 · $1MNIH RePORTER 5R44HL169181-03 · fetched Nov 12, 2026
- Targeting LRRC8 signaling to prevent & treat arterial thrombosis in type 2 diabetesFiscal year 2024 · $982.2KNIH RePORTER 4R44HL169181-02 · fetched Nov 12, 2026